46 studies found for:    stroke AND san diego | Open Studies
Show Display Options
Rank Status Study
21 Unknown  Oxygenation of the Cerebrum and Cooling During Transcatheter Aortic Valve Implantation (TAVI) Procedures - Part II
Conditions: Aortic Valve Stenosis;   Stroke
Interventions: Device: targeted brain cooling (33°C) by RhinoChill device;   Device: Placebo - current clinical practice, no cooling
22 Recruiting Effect of Albiglutide, When Added to Standard Blood Glucose Lowering Therapies, on Major Cardiovascular Events in Subjects With Type 2 Diabetes Mellitus
Condition: Diabetes Mellitus
Interventions: Biological: Albiglutide 30 mg;   Biological: Albiglutide 50 mg;   Biological: Albiglutide matching placebo
23 Not yet recruiting A Trial Investigating the Cardiovascular Safety of Oral Semaglutide in Subjects With Type 2 Diabetes
Conditions: Diabetes;   Diabetes Mellitus, Type 2
Interventions: Drug: semaglutide;   Drug: placebo
24 Recruiting A Trial Comparing Cardiovascular Safety of Degarelix Versus Leuprolide in Patients With Advanced Prostate Cancer and Cardiovascular Disease
Condition: Prostate Cancer
Interventions: Drug: Degarelix;   Drug: Leuprolide
25 Recruiting Cardiovascular and Renal Microvascular Outcome Study With Linagliptin in Patients With Type 2 Diabetes Mellitus (CARMELINA)
Condition: Diabetes Mellitus, Type 2
Interventions: Drug: Placebo;   Drug: Linagliptin
26 Not yet recruiting Comparison of Standard CDT vs. USAT for Patients With Acute Submassive PE
Condition: Pulmonary Embolism
Interventions: Procedure: CDT without ultrasound acceleration;   Procedure: CDT with ultrasound acceleration
27 Recruiting Vein of Marshall Ethanol Infusion for Persistent Atrial Fibrillation
Conditions: Ventricular Tachycardia;   Atrial Fibrillation
Interventions: Drug: Ethanol;   Procedure: Ablation
28 Recruiting Calibrating Cardiac Output Measurement of Electrical Cardiometry With Transthoracic Echocardiography
Condition: Coronary Artery Disease
Interventions: Other: passive leg raising test;   Procedure: right heart catheterisation;   Other: TTE vs. EC + calibration group
29 Recruiting Study Of Diabetic Nephropathy With Atrasentan
Condition: Diabetic Nephropathy
Interventions: Drug: Atrasentan;   Drug: Placebo
30 Recruiting Outcomes Study to Assess STatin Residual Risk Reduction With EpaNova in HiGh CV Risk PatienTs With Hypertriglyceridemia
Condition: Eligible Men or Women Considered High Risk for Atherosclerotic Cardiovascular Disease (CVD)
Interventions: Drug: Epanova® (omega-3 carboxylic acids);   Drug: corn oil control
31 Recruiting A Study of Apixaban in Patients With Atrial Fibrillation, Not Caused by a Heart Valve Problem, Who Are at Risk for Thrombosis (Blood Clots) Due to Having Had a Recent Coronary Event, Such as a Heart Attack or a Procedure to Open the Vessels of the Heart
Condition: Acute Coronary Syndromes
Interventions: Drug: Apixaban;   Drug: vitamin K antagonist;   Drug: Acetylsalicylic acid;   Other: Acetylsalicylic acid placebo
32 Recruiting A Study of AMR101 to Evaluate Its Ability to Reduce Cardiovascular Events in High Risk Patients With Hypertriglyceridemia and on Statin. The Primary Objective is to Evaluate the Effect of 4 g/Day AMR101 for Preventing the Occurrence of a First Major Cardiovascular Event.
Condition: Cardiovascular Diseases
Interventions: Drug: AMR101;   Drug: Placebo
33 Recruiting Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and the Clinical Diagnosis of Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Interventions: Drug: Finerenone (BAY94-8862);   Drug: Placebo
34 Recruiting Safety and Efficacy of Low-Dose Ticagrelor in Chinese Patients With NSTE-ACS
Condition: Non ST Segment Elevation Acute Coronary Syndrome
Interventions: Drug: low-dose ticagrelor;   Drug: conventional-dose ticagrelor;   Drug: Clopidogrel
35 Recruiting Efficacy and Safety of AMG0001 in Subjects With Critical Limb Ischemia
Condition: Critical Limb Ischemia
Interventions: Genetic: HGF Plasmid (AMG0001);   Genetic: Matching Placebo
36 Recruiting Advancing Research and Treatment for Frontotemporal Lobar Degeneration (ARTFL)
Conditions: FTLD;   Progressive Supranuclear Palsy (PSP);   Frontotemporal Dementia (FTD);   Corticobasal Degeneration (CBD);   PPA Syndrome;   Behavioral Variant Frontotemporal Dementia (bvFTD);   Semantic Variant Primary Progressive Aphasia (svPPA);   Nonfluent Variant Primary Progressive Aphasia (nfvPPA);   FTD With Amyotrophic Lateral Sclerosis (FTD/ALS);   Amyotrophic Lateral Sclerosis (ALS);   Oligosymptomatic PSP (oPSP);   Corticobasal Syndrome (CBS)
Intervention:
37 Recruiting Efficacy and Safety of Finerenone in Subjects With Type 2 Diabetes Mellitus and Diabetic Kidney Disease
Condition: Diabetic Kidney Disease
Interventions: Drug: Finerenone (BAY94-8862);   Drug: Placebo
38 Recruiting Efficacy and Safety of LCZ696 Compared to Valsartan, on Morbidity and Mortality in Heart Failure Patients With Preserved Ejection Fraction
Condition: Heart Failure With Preserved Ejection Fraction
Interventions: Drug: LCZ696;   Drug: Valsartan
39 Recruiting Phenotype, Genotype & Biomarkers in ALS and Related Disorders
Conditions: Amyotrophic Lateral Sclerosis;   Frontotemporal Dementia;   Primary Lateral Sclerosis;   Hereditary Spastic Paraplegia;   Progressive Muscular Atrophy;   Multisystem Proteinopathy
Intervention:
40 Recruiting Minimally Invasive Surgery Plus Rt-PA for ICH Evacuation Phase III
Condition: Intracerebral Hemorrhage
Intervention: Drug: rt-PA

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-46) Show next page of results    Last Page
Indicates status has not been verified in more than two years